Missing/wrong data? Edit Wikidata item
TRIB2 confers resistance to anti-cancer therapy by activating the serine/threonine protein kinase AKT.
scientific article
Author/s
Work details
Publication date:
March 9, 2017
Language:
English
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.